Aerovate Therapeutics Stock Price on January 31, 2024

AVTE Stock  USD 2.53  0.03  1.17%   
If you're considering investing in Aerovate Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aerovate Therapeutics stands at 2.53, as last reported on the 22nd of December, with the highest price reaching 2.64 and the lowest price hitting 2.45 during the day. Aerovate Therapeutics appears to be somewhat reliable, given 3 months investment horizon. Aerovate Therapeutics secures Sharpe Ratio (or Efficiency) of 0.14, which signifies that the company had a 0.14% return per unit of risk over the last 3 months. By analyzing Aerovate Therapeutics' technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please makes use of Aerovate Therapeutics' Risk Adjusted Performance of 0.1044, mean deviation of 2.34, and Downside Deviation of 2.41 to double-check if our risk estimates are consistent with your expectations.
  
At present, Aerovate Therapeutics' Stock Based Compensation is projected to increase significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 53.1 M, whereas Liabilities And Stockholders Equity is forecasted to decline to about 98.2 M. . At present, Aerovate Therapeutics' Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 5.72, whereas Price Earnings To Growth Ratio is forecasted to decline to (0.23). Aerovate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1445

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsAVTE
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.52
  actual daily
31
69% of assets are more volatile

Expected Return

 0.51
  actual daily
10
90% of assets have higher returns

Risk-Adjusted Return

 0.14
  actual daily
11
89% of assets perform better
Based on monthly moving average Aerovate Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aerovate Therapeutics by adding it to a well-diversified portfolio.
Price Book
0.9159
Book Value
2.788
Enterprise Value
-14.5 M
Enterprise Value Ebitda
(9.33)
Shares Float
11.8 M

Aerovate Therapeutics Main Headline on 31st of January 2024

Filed transaction by Aerovate Therapeutics Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Aerovate Therapeutics Valuation on January 31, 2024

It is possible to determine the worth of Aerovate Therapeutics on a given historical date. On January 31, 2024 Aerovate was worth 19.0 at the beginning of the trading date compared to the closed value of 19.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Aerovate Therapeutics stock. Still, in general, we apply an absolute valuation method to find Aerovate Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aerovate Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Aerovate Therapeutics' related companies.
 Open High Low Close Volume
  17.87    19.08    17.87    18.83    56,646  
01/31/2024
  19.00    20.64    18.82    19.31    70,545  
  19.28    19.50    18.25    18.69    62,916  
Backtest Aerovate Therapeutics  |  Aerovate Therapeutics History  |  Aerovate Therapeutics Valuation   PreviousNext  
Open Value
19.0
19.31
Closing Value
29.55
Upside

Aerovate Therapeutics Trading Date Momentum on January 31, 2024

On February 01 2024 Aerovate Therapeutics was traded for  18.69  at the closing time. The top price for the day was 19.50  and the lowest listed price was  18.25 . The trading volume for the day was 62.9 K. The trading history from February 1, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.21% . The overall trading delta against the current closing price is 8.75% .

Aerovate Therapeutics Fundamentals Correlations and Trends

By evaluating Aerovate Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Aerovate Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Aerovate financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Aerovate Therapeutics Stock history

Aerovate Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aerovate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aerovate Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aerovate Therapeutics stock prices may prove useful in developing a viable investing in Aerovate Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding26.3 M27.3 M
Net Loss-20.7 M-19.7 M

Aerovate Therapeutics Quarterly Net Working Capital

93.74 Million

Aerovate Therapeutics Stock Technical Analysis

Aerovate Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Aerovate Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aerovate Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Aerovate Therapeutics Period Price Range

Low
December 22, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Aerovate Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Aerovate Therapeutics December 22, 2024 Market Strength

Market strength indicators help investors to evaluate how Aerovate Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aerovate Therapeutics shares will generate the highest return on investment. By undertsting and applying Aerovate Therapeutics stock market strength indicators, traders can identify Aerovate Therapeutics entry and exit signals to maximize returns

Aerovate Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Aerovate Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Aerovate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aerovate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Aerovate Stock analysis

When running Aerovate Therapeutics' price analysis, check to measure Aerovate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aerovate Therapeutics is operating at the current time. Most of Aerovate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aerovate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aerovate Therapeutics' price. Additionally, you may evaluate how the addition of Aerovate Therapeutics to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Global Correlations
Find global opportunities by holding instruments from different markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios